SCOPE 2023: Reducing Readmissions in High-Risk Patients

Article

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures talks about his recently-founded company and its mission to reduce readmissions for high-risk patients with chronic diseases using voice-enabled natural language processing technology.

Recent Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.